GLUCAGON-LIKE PEPTIDE CLEAVAGE PRODUCT AS A POTENTIAL THERAPEUTIC TO IMPROVE COGNITION IN DOWN SYNDROME

Day, Stephen Mathew

Back to search

Wake Forest University

GLUCAGON-LIKE PEPTIDE CLEAVAGE PRODUCT AS A POTENTIAL THERAPEUTIC TO IMPROVE COGNITION IN DOWN SYNDROME

dc:creator Day, Stephen Mathew

dc:date.issued2018

Abstract

dc:description.abstract

ABSTRACT

Degree

thesis:*

Grantor dc:publisher: Wake Forest University
Year dc:date.issued: 2018

Author and committee

dc:creator, dc:contributor.*

Author dc:creator: Day, Stephen Mathew

Subjects

dc:subject × 1

Down's syndrome

Rights

Language dc:language.iso: en

Identifiers

dc:identifier.*

Handle dc:identifier.uri: http://hdl.handle.net/10339/93047
OAI identifier oai:identifier: oai:wakespace.lib.wfu.edu:10339/93047

Chain of custody

source

Harvested from: Wake Forest University
Base URL: wakespace.lib.wfu.edu/oai/request
Last updated: 2026-07-27
Source record: OAI-PMH GetRecord

related terms

citation

Day, Stephen Mathew. GLUCAGON-LIKE PEPTIDE CLEAVAGE PRODUCT AS A POTENTIAL THERAPEUTIC TO IMPROVE COGNITION IN DOWN SYNDROME. Wake Forest University, 2018. http://hdl.handle.net/10339/93047

GLUCAGON-LIKE PEPTIDE CLEAVAGE PRODUCT AS A POTENTIAL THERAPEUTIC TO IMPROVE COGNITION IN DOWN SYNDROME

Abstract

Degree

Author and committee

Subjects

Rights

Identifiers

Chain of custody

More from Wake Forest University